No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Scott Gray?

Mr. Scott A. Gray

Chief Executive Officer


HQ Phone: (888) 458-8579

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.


833 Chestnut Street 12th Floor

Philadelphia, Pennsylvania 19107

United States

Company Description

Clincierge provides unique, customizable services aimed at overcoming barriers to patient participation in clinical studies. Our goal is to aid drug developers in reducing overall clinical testing time and cost, thus helping to get new treatments to the m ... more

Find other employees at this company (28)

Background Information

Employment History

Chief Executive Officer

Gray Consulting International Meetings & Incentives


Founding Member of the Certification Committee
The International Medical Meetings Professionals Association

Philadelphia Business Journal's List

Advisory Board Member
The Motivation Show

Meeting Professionals International


Faculty Member of the Mathematics Department
University of Illinois




Ohio State University

Web References (126 Total References)

- Clincierge® CEO Scott Gray ... [cached]

- Clincierge® CEO Scott Gray to Chair Day One of World Orphan Drug Congress -

Philadelphia, PA (April 19, 2016): Clincierge® will showcase the company's unique hospitality-driven services that support clinical trial recruitment and patient retention at World Orphan Drug Congress U.S.A 2016, being held in Washington DC from April 20 - 22. Additionally, Clincierge® Chief Executive Officer Scott Gray will chair the first day of the Main Conference, April 21.
"Clinical trial sites for Orphan Drug studies are often widely dispersed, making multi-national trials and the necessity of patient travel a significant challenge for sponsors and CROs that can lead to slow recruitment and frequent patient drop-outs," says Scott Gray, chief executive officer of Clincierge®.
Scott A. Gray, CEO Clincierge ®, a division of Gray Consulting International office: +1-215-413-7880

- Scott Gray, Co-Founder and ... [cached]

- Scott Gray, Co-Founder and CEO, CLINCIERGE

Scott A. ... [cached]

Scott A. Gray CEO direct: 215.413.7880

Since 1982 Scott has been in the travel and meeting planning industry, with oversight of sales leadership, sourcing, meeting services, and information technology. Scott is sought out by clients seeking to improve ROI/ROE through the application of his experience with people logistics, meeting architecture and organization development.

"We are pleased to receive this ... [cached]

"We are pleased to receive this recognition for our efforts to help patients access and remain in clinical trials and to help trial sponsors and clinical research organizations to reduce clinical testing time and cost, as well as maximize the quality of data obtained," said Scott Gray, Clincierge chief executive officer.

Scott A. Gray, CEO Clincierge ®, a division of Gray Consulting International office: +1-215-413-7880

Philadelphia, PA (October 15, 2015): ... [cached]

Philadelphia, PA (October 15, 2015): Putting the needs of clinical trial participants and their families first can help remove barriers to trial enrollment and patient retention, according to Scott Gray, Chief Executive of Clincierge, a provider of specialized services that increase the patient-centricity of clinical drug development. The result is fewer of the delays that greatly inflate drug development costs and shorter times to getting innovative therapies to those who need them.

Rethinking patient engagement and the use of new approaches that reduce burdens for clinical trial stake holders, thus increasing their willingness and ability to participate and remain on study will be the topic of discussion for a panel on October 20 entitled "Address Trial Fatigue through Innovation: Time to Rethink Patient Engagement 2.0." The panel, which will include the views of Stage 4 melanoma survivor and patient advocate, T.J. Sharpe, and Alnylam Pharmaceuticals' Associate Director of Clinical Operations, Mary West, as well as those of Mr. Gray, is being conducted as part of the eyeforpharma Patient-Centered Clinical Trials 2015 conference, being held on October 19-20 in Philadelphia, PA.
"Poor patient recruitment and retention in clinical trials is one of the greatest challenges faced by drug developers today and a major contributor to the escalating costs of drug development," said Mr. Gray.
Scott A. Gray, CEO, Clincierge
Scott A. Gray, CEO Clincierge™, a division of Gray Consulting International office: +1-215-413-7880

Similar Profiles

Other People with this Name

Other people with the name Gray

Campbell Gray
The University of Queensland

Christine Gray
Choice Homes

David Gray
Jones Lang LaSalle Incorporated

Charles Gray

Gerald Gray
Scientific Research Corporation

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory